HONG KONG DRUG LICENSING

Hong Kong Drug Licence FAQs

Search 500 Hong Kong drug licence FAQs on applications, personnel, premises, quality systems, ongoing regulation, renewals and acquisitions.

Information status: The original FAQ material dates from 2025 and is provided for topic-based reference; it does not represent an individual verification of all 500 FAQs against current rules. For application, fee, renewal, change, product or prescription requirements, please refer to the current official forms and guidance.

Official information from the Drug Office Official information from the Chinese Medicines Board

找到 50 条结果，第 2／3 页。每页显示 20 条；无需启用 JavaScript。

Thematic illustration for pharmaceutical licensing business queries and document organisation services — Discuss actual operating questions one-to-one to clarify the next decision.

Q221 · 申请“获授权毒药销售商”（药房）牌照与批发商牌照在审批程序上有何核心差异？独立链接

Applying for an “Authorised Seller of Poisons” (ASP) licence, commonly known as a community pharmacy licence, differs fundamentally from applying for a Wholesale Dealer Licence in terms of procedures and requirements. The key differences concern staffing and the function of the premises. A pharmacy must have a registered pharmacist present to personally supervise the sale of all controlled medicines, which means you must employ a full-time registered pharmacist. A wholesale dealer, on the other hand, must appoint a Responsible Person (RP). As for the premises, a pharmacy is a retail shop open to the public, and its layout, design and location should facilitate access to medicines by the public, with a dedicated dispensing area and consultation area. A wholesaler's warehouse is a non-public storage and logistics centre. As with a pharmacy application, the approval process involves an on-site inspection by the Department of Health and approval by the PPB committee, but the inspection focuses more on compliance in retail operations, the pharmacist's presence and the management of prescription medicines.

📘 Regulatory basis

The Pharmacy and Poisons Regulations have a dedicated section setting out the operating conditions for Authorised Sellers of Poisons, including the requirement for supervision by a registered pharmacist. The Code of Practice for the Guidance of Pharmacy issued by the PPB provides detailed guidance for retail operations.

📗 Drew Tang's recommendations

For clients planning to open a pharmacy, our first recommendation is “people before premises”: secure a registered pharmacist to work with you first. An experienced and reputable pharmacist is key to a successful application. We can assist with recruitment and background checks, and design and fit out your shop in accordance with the pharmacist’s professional advice, ensuring that the layout complies with regulations and is practical to operate.

📕 Risk notice

The greatest risk is the stability of the pharmacist. If your pharmacist leaves during the application process or shortly after approval, and you cannot find a replacement immediately, your licence application may be suspended. A pharmacy that has already opened must also immediately stop selling all controlled medicines; otherwise, it would be operating unlawfully, with very serious consequences.

Q222 · 一家海外的药品公司可以直接在香港申请药品牌照吗，还是必须先成立香港公司？独立链接

This is a crucial question: determining whether your product is “food” or “medicine” is the first step. In Hong Kong, if your product meets the definition of a “proprietary Chinese medicine” under the Chinese Medicine Ordinance—that is, its active ingredients consist solely of Chinese herbal medicines and it is intended to diagnose, treat or prevent disease or regulate the functions of the human body—you need to apply for a Manufacturer of Proprietary Chinese Medicines Licence and comply with the GMP requirements for proprietary Chinese medicines. If the ingredients are not regarded as Chinese herbal medicines, or the health claims made do not involve therapeutic effects, the product may be classified as “food” or “health food” and regulated by the Centre for Food Safety (CFS), without requiring a pharmaceutical licence. However, the dividing line may be unclear.

📘 Regulatory basis

The Business Registration Ordinance (Cap. 310) requires anyone carrying on business in Hong Kong to obtain business registration. The Department of Health’s licensing guidance also expressly requires applicants to be Hong Kong legal entities.

📗 Drew Tang's recommendations

We provide many international pharmaceutical companies with a one-stop service for establishing a presence in Hong Kong. We will promptly handle the registration of your Hong Kong company and provide professional advice on its shareholding structure, director appointments and other matters, ensuring that it is consistent with the parent company's global strategy and meets local Hong Kong regulatory requirements. We will ensure that the company establishment and licence application processes dovetail seamlessly, saving you valuable time.

📕 Risk notice

The risk lies in misunderstanding the requirement for a Hong Kong legal entity. Some overseas companies may assume that they can apply directly using their globally recognised parent company’s brand, delaying the establishment of a Hong Kong subsidiary. This will delay the entire project timeline, because all subsequent steps, such as signing a tenancy agreement, must be carried out in the name of the Hong Kong company.

Q223 · 在申请批发商牌照时，对“负责人”（RP）的具体资质和经验有何量化要求？独立链接

The regulatory authority’s requirements for the qualifications of a ‘Responsible Person’ (RP) combine principle-based assessment with flexibility. There is no absolute quantitative standard; each case is assessed individually. PPB guidance states that an RP should have appropriate qualifications and experience. In practice, a Hong Kong registered pharmacist is the ideal candidate, as their qualifications are almost certain to be recognised. If the candidate is not a pharmacist, they will need to demonstrate sufficient relevant experience and knowledge of the pharmaceutical industry. This generally means: 1) a degree in a relevant subject, such as pharmacy, pharmacology or biochemistry; 2) several years’ work experience in pharmaceutical wholesale, manufacturing or quality management, particularly in a management role; and 3) familiarity with Hong Kong pharmaceutical regulations and GSDP (Good Storage and Distribution Practice). When applying, you will need to submit the RP’s detailed CV, academic qualifications and evidence of previous employment for the Department of Health to assess.

📘 Regulatory basis

The Code of Practice for Wholesale Dealers requires licence holders to appoint a person-in-charge and ensure that they have the appropriate qualifications, experience and knowledge to discharge their duties effectively. The PPB Board makes the final determination on whether the nominee is “fit and proper” when considering the application.

📗 Drew Tang's recommendations

Adding value to an RP candidate’s CV is one of our specialities. We will guide you in drafting the RP’s CV to highlight experience relevant to pharmaceutical quality management and regulatory compliance, rather than making general statements. We will also provide the RP with intensive pre-appointment training to ensure that, when responding to inspectors’ questions, they can demonstrate a thorough understanding of GSDP and Hong Kong regulations, thereby gaining the regulatory authority’s confidence.

📕 Risk notice

The greatest risk is appointing someone to a role beyond their capabilities. For example, appointing an RP with sales experience but no quality management background, or a newly graduated pharmacy student with no practical experience. Even if their stated qualifications appear relevant, their lack of knowledge and experience may become apparent during an in-depth discussion with inspectors, potentially becoming a key reason for delay or refusal of the application.

Q224 · 在初次提交申请时，我的标准操作程序（SOPs）需要准备到多详细的程度？独立链接

You do not need to submit a perfect final set of SOPs covering every detail with your initial application. However, you must prepare a core set of clearly structured draft SOPs to demonstrate to the regulator that you have systematically considered and planned your future operational processes. These drafts should cover at least all key areas of GSDP (Good Storage and Distribution Practice), including personnel and training, premises and equipment management, document control, receipt, storage, order processing, dispatch, transport, complaint handling, medicine recalls, returned goods handling and internal audits. Each SOP should have a clear title, purpose, scope, allocation of responsibilities and description of steps. During an on-site inspection, inspectors will sample these SOPs and may ask your Person-in-Charge about the procedures they describe to assess whether your quality management system is tangible and effective.

📘 Regulatory basis

The Code of Practice for Wholesale Dealers expressly requires licence holders to establish and maintain an effective Quality Management System, with SOPs as its core documentary evidence. Inspectors need to review your SOPs to assess your ability to ensure ongoing compliance.

📗 Drew Tang's recommendations

We will not leave you to start from scratch. RGYS may assist with document preparation and project coordination within the written scope of services; the respective responsible parties must verify personnel qualifications and statutory roles and take responsibility for professional judgements, while approval is determined independently by the competent authority. Based on your specific business model (for example, whether you handle cold-chain products), we will customise a set of draft SOPs to meet your needs. These documents can not only readily pass the initial review but, more importantly, are highly practical and can genuinely guide your future day-to-day work, rather than merely serving to satisfy inspections.

📕 Risk notice

The risk lies in submitting SOPs copied from the internet that are hollow and unrealistic. For example, the processes described may not match your warehouse layout, or the wrong terminology may be used. An experienced inspector will immediately recognise that the document is “theoretical” and may seriously question your professional competence and the sincerity of your application, resulting in unusually rigorous scrutiny.

Q225 · 如果在现场视察时，督察发现了一些轻微的缺陷（minor defects），会发生什么？独立链接

If a pharmacist inspector identifies “minor defects” during an on-site inspection, this will not usually lead to your application being refused outright. Minor defects are small issues that do not directly affect medicine safety or quality and can be corrected promptly. Examples include failing to update a cleaning record for one area, a minor formatting error in a non-core SOP, or an unclear label on a shelf. In such cases, the inspector will usually point out the issues orally at the end of the inspection or in a subsequent inspection report. You must complete the corrective actions within the specified period (for example, one to two weeks) and respond to the Department of Health in writing with evidence that the actions have been completed, such as photographs or updated documents. Provided that you complete the corrective actions promptly and effectively, these minor defects will generally not affect the PPB’s positive assessment of your application.

📘 Regulatory basis

When conducting assessments, regulatory authorities generally classify deficiencies according to a risk-based approach (for example, as critical, major or minor). The way minor deficiencies are handled reflects a proportionate and flexible approach to regulation, aimed at helping applicants improve their systems rather than simply penalising them.

📗 Drew Tang's recommendations

We take a “zero-tolerance” approach to “minor deficiencies”. Through our rigorous pre-inspection process, we aim to eliminate all visible deficiencies, whether major or minor, before the official inspection. If an unexpected minor issue does arise during the inspection, we will respond immediately, guide you to complete corrective action within 24 hours and prepare the response documents, demonstrating to the inspector your efficient execution and proactive compliance approach, and turning a minor issue into a positive.

📕 Risk notice

The risk lies in disregarding “minor deficiencies”. If you ignore issues raised by inspectors, delay corrective action or take only superficial measures, those minor deficiencies may be escalated into major concerns about “non-cooperation” or “lack of commitment to compliance”. This could fundamentally change the inspector’s view of you and may result in a negative report to the PPB.

Q226 · 在等待牌照批准期间，我是否可以开始进行一些商业活动，例如市场推广或与客户签订意向书？独立链接

This is a matter where the boundary must be absolutely clear. Before you formally obtain a pharmaceutical licence issued by the PPB, you must not carry out any business activity within the scope of the licence. Specifically, you must not import, export, wholesale, sell, distribute or store any pharmaceutical products. Any of these activities would constitute operating without a licence, which is a serious criminal offence. However, preparatory business activities that do not involve actual transactions in pharmaceutical products are permitted. For example, you may conduct market research, design your company website (but not sell pharmaceutical products online), make initial contact with potential suppliers or customers, discuss a framework for cooperation, or even sign a non-legally binding letter of intent (LOI) or memorandum of understanding (MOU), provided that the documents clearly state that all cooperation can only proceed once you have formally obtained the licence.

📘 Regulatory basis

Section 29 of the Pharmacy and Poisons Ordinance expressly provides that no person may sell or distribute any poison unless they are an authorised seller. The penalties for operating without a licence are severe and include substantial fines and imprisonment.

📗 Drew Tang's recommendations

We recommend that clients use the waiting period to focus on “strengthening internal capabilities”, for example by improving internal SOPs, providing staff with GSDP training, and establishing customer and supplier files. During commercial negotiations with external parties, we will review letters of intent or draft contracts to ensure that the terms clearly link the start of the actual transaction to the licence grant date, helping you mitigate legal risks.

📕 Risk notice

The greatest risk is “jumping the gun”. Some applicants, in an attempt to gain a foothold in the market, may accept orders or even import small quantities of goods before obtaining a licence. If the Department of Health discovers this, whether following a complaint or a Customs spot check, your licence application may be suspended and refused immediately, and the company and its directors may also face criminal prosecution, with potentially devastating consequences for the business. Do not break the law.

Q227 · 药品牌照的续期（Renewal）流程是怎样的？会像首次申请一样复杂吗？独立链接

The renewal process for a pharmaceutical licence is much simpler than the first-time application, provided your company has maintained a good compliance record throughout the licensing period. Pharmaceutical licences in Hong Kong are usually valid for one year. You need to submit a renewal application to the Department of Health within a period before the licence expires (usually 1–3 months). The renewal application must be made on the prescribed form, with the relevant renewal fee paid. Unlike a first-time application, you generally do not need to resubmit the full set of company documents or SOPs, unless your company has undergone a significant change in the past year, such as moving premises or changing the Person-in-Charge. When reviewing renewal applications, the Department of Health will focus on your compliance over the past year, including whether there have been any breaches or warning letters, and your performance during previous spot checks. If your record is good, renewal will usually be approved smoothly without another full on-site inspection.

📘 Regulatory basis

The Pharmacy and Poisons Regulations contain provisions on licence validity and renewal. The Department of Health will decide whether to approve a renewal based on the licence holder’s overall compliance during the licence period.

📗 Drew Tang's recommendations

We provide “worry-free renewal” services to our annual service clients. We will remind you in advance to start the renewal process, prepare all renewal documents for you and ensure that you do not miss any deadlines. More importantly, we provide ongoing compliance advice throughout the year to help you maintain an excellent compliance record, so that each renewal is simply an administrative procedure rather than a new test.

📕 Risk notice

The risk is a “poor compliance record”. If you commit repeated breaches while licensed, or serious issues are found during a surprise inspection by the Department of Health, your renewal application will face considerable challenges. The Department may require comprehensive corrective action and may even convene a hearing to decide whether to revoke your licence. Ongoing compliance is therefore fundamental to ensuring smooth renewal year after year.

Q228 · 对于需要冷链运输的药品，在申请牌照时，对仓库和流程有何特殊要求？独立链接

Handling drugs requiring cold-chain management (such as vaccines and biologics) imposes far stricter requirements on warehouse facilities and operating procedures than handling ambient-temperature drugs. When applying for a licence, you must demonstrate to the Department of Health that you have full cold-chain management capabilities. For the warehouse, you must have dedicated, validated refrigeration equipment (usually refrigerators or cold rooms maintained at 2–8°C). This equipment must have an independent, continuous temperature and humidity monitoring and recording system with an alarm function. Your SOPs must contain dedicated sections describing in detail the entire process for receiving, storing, picking, packing and transporting cold-chain products. You must use validated refrigerated transport containers and data loggers, and ensure that the temperature remains within the required range at every stage from your warehouse to the customer. During an on-site inspection, inspectors will examine your cold-chain facilities and procedures in great detail.

📘 Regulatory basis

The Code of Practice for Wholesale Dealers published by the PPB and the PIC/S GSDP Guide both include detailed requirements for the storage and transport of temperature-sensitive medicines. These are the main standards regulators use to assess your cold-chain capabilities.

📗 Drew Tang's recommendations

We recommend that clients planning to handle cold-chain products invest in establishing a robust cold-chain system at the outset of the project. We will recommend reliable equipment suppliers and validation service providers, and draft a world-class set of cold-chain management SOPs for you. We will also guide you through transport validation to ensure that your cold-chain logistics solution is robust and can withstand the regulator’s most stringent scrutiny.

📕 Risk notice

The greatest risk is a “fake cold chain”. For example, using a domestic refrigerator to store vaccines, or using ordinary ice packs during transport without a validated refrigerated container and temperature records. A temperature excursion at any stage may render the medicine ineffective and pose a serious safety risk to patients. If such a problem is found during an inspection, your licence application will be refused immediately.

Q229 · 如果我只计划批发一种风险极低的非处方药（OTC），申请要求会因此而放宽吗？独立链接

📘 Regulatory basis

Neither the Pharmacy and Poisons Ordinance nor the Code of Practice for Wholesale Dealers establishes different licence grades or application requirements for medicines with different risk levels. All applicants must meet the same GSDP (Good Storage and Distribution Practice) standard.

📗 Drew Tang's recommendations

Although the application standards are not reduced, we can design a more cost-effective compliance solution to suit your simple business model. For example, your premises may be relatively small and your SOP processes may be relatively straightforward, such as not involving complex recall or complaint-handling procedures. We will help you find the most economical operating model while remaining fully compliant, avoiding over-engineering and matching your initial investment to the scale of your business.

📕 Risk notice

The risk lies in the mistaken expectation that “requirements will be relaxed”, leading to carelessness in preparation. For example, you might assume that a low-risk product means you can simply rent an office as a warehouse, or let a company administrator double as the person responsible. This would put you on the wrong track from the very first step of the application, wasting considerable time and resources.

Q230 · 在申请文件中，除了负责人（RP），是否还需要任命“副负责人”（Deputy RP）？独立链接

Appointing a Responsible Person (RP) is a mandatory legal requirement when applying for a pharmaceutical licence in Hong Kong. However, the regulations do not require the appointment of a Deputy RP. Whether to appoint one is a business decision for the company. Nevertheless, from the perspective of sound operations and risk management, we strongly recommend nominating one or two deputy Responsible Persons at the time of application. Their main role is to take over immediately if the RP is on leave, travelling or otherwise unable to fulfil their duties, ensuring that there is no “compliance gap” in the company’s operations. Demonstrating during a site inspection or when communicating with the regulatory authorities that you have a clear contingency plan and succession arrangements will make a professional and well-considered impression.

📘 Regulatory basis

The Code of Practice for Wholesale Dealers emphasises that licence holders need sufficient qualified personnel to perform the various tasks. Although it does not expressly require a “deputy person-in-charge”, appointing a deputy is fully consistent with the legislative intent of “ensuring the quality of medicines and business continuity”.

📗 Drew Tang's recommendations

We will clearly include the deputy RP’s role and responsibilities in the organisation chart and SOPs prepared for you. The deputy may be another member of the company’s management team with a relevant background. We will provide them with the same training to ensure that they clearly understand their responsibilities when the RP is absent. This seemingly small measure sends a strong message to the PPB Committee: your company has a mature and resilient management team.

📕 Risk notice

The risk of not having a deputy responsible person is operational vulnerability. Imagine that your company has only one RP and they suddenly need to take long-term sick leave. Your entire licensed business may come to a standstill because there is no second person who can lawfully oversee the release of medicines. This “single point of failure” is a risk that both mature businesses and prudent regulatory authorities seek to avoid.

Q231 · 我是否可以委托第三方物流公司（3PL）来储存和运输我的药品？如果可以，申请流程有何不同？独立链接

Yes, you may outsource medicine storage and/or transport to a suitably qualified third-party logistics provider (3PL). This is a very common business model in the industry, particularly for companies seeking to operate an asset-light business. If you choose this approach, your application process will change significantly. You will no longer need to lease and fit out a medicine warehouse yourself. Instead, you will need to enter into a detailed service contract with a 3PL company that already holds a valid Wholesale Dealer Licence for medicines. You must submit this contract with your licence application and clearly define the responsibilities of your company and the 3PL. You will still need to establish a Hong Kong company and appoint an RP, but the RP's main responsibility will shift from managing a physical warehouse to overseeing and auditing the 3PL's service quality, ensuring that its operations comply with GSDP requirements and your company's SOPs. The Department of Health may conduct on-site inspections at your office and the 3PL's warehouse, either at the same time or separately.

📘 Regulatory basis

The Code of Practice for Wholesale Dealers has a dedicated section on “Outsourced Activities”. It expressly provides that the licence holder (that is, you) retains ultimate responsibility for any outsourced activity, must ensure that the contractor (3PL) is capable of providing compliant services, and must effectively oversee it.

📗 Drew Tang's recommendations

Choosing a reliable 3PL partner is crucial. RGYS may assist with document preparation and project coordination within the written scope of services; the respective responsible parties must verify personnel qualifications and statutory roles and take responsibility for professional judgements, while approval is determined independently by the competent authority. We will assist you in conducting due diligence, selecting the partner best suited to your business needs, and drafting a Technical Agreement that clearly defines rights and responsibilities and meets regulatory requirements. This agreement will be one of the key documents for the success of your application.

📕 Risk notice

The greatest risk is thinking that outsourcing everything will solve the problem. If you believe you can relax once logistics have been outsourced, you are seriously mistaken. If your 3PL partner is found to have committed serious breaches during a subsequent inspection, you, as the commissioning party and licence holder, may also be legally liable, and your licence may likewise be suspended or revoked. Ongoing supplier audits and quality oversight are therefore essential.

Q232 · 申请“列载毒药销售商”（Listed Seller of Poisons）牌照的审批程序与药房有何不同？独立链接

Applying for a “Listed Seller of Poisons” (LSP) licence usually refers to what are commonly known as a “dispensary” or “drug shop”. Its approval process and scope of business differ significantly from those of an “Authorised Seller of Poisons” (Pharmacy). The key distinction is that an LSP may sell only Part II poisons in the First Schedule (commonly called “P2 medicines”, such as some painkillers and cold medicines), and may not sell prescription medicines or P1 medicines that require pharmacist supervision. Although an application must also be submitted to the Department of Health and the premises are subject to an on-site inspection, the requirements are relatively less stringent. A registered pharmacist does not need to be present on the premises, but staff must have received appropriate training. The premises must have a dedicated locked cabinet for storing P2 medicines, which must not be displayed where customers can help themselves. The focus of approval is to ensure that the applicant can store and sell these restricted non-prescription medicines safely.

📘 Regulatory basis

The Pharmacy and Poisons Regulations set out clear requirements for Listed Sellers of Poisons’ qualifications, premises conditions and sales methods. For example, they provide that such shops must renew their licences every January.

📗 Drew Tang's recommendations

For clients wishing to enter pharmaceutical retail but currently unable to engage a registered pharmacist, applying for a Listed Seller of Poisons licence is a good starting point. We will guide you on fitting out your shop correctly and installing compliant lockable cabinets, and provide your employees with training on the regulations governing sales of P2 medicines. RGYS may assist with document preparation and project coordination within the written scope of services; the respective responsible parties must verify personnel qualifications and statutory roles and take responsibility for professional judgements, while approval is determined independently by the competent authority, for lawful operation.

📕 Risk notice

The greatest risk is “selling beyond the permitted scope”. Some pharmacy owners may illegally sell P1 medicines requiring pharmacist supervision or prescription medicines for profit. This is a very serious offence. If discovered through a test purchase or inspection, the licence may be revoked immediately and the operator may face imprisonment. The permitted scope of business must be followed strictly.

Q233 · 卫生署的药剂师督察在进行现场视察时，是否有固定的检查清单（checklist）？独立链接

Yes, during on-site inspections, Department of Health pharmacy inspectors assess the premises against a detailed internal checklist. The checklist is based on the Pharmacy and Poisons Ordinance and relevant codes of practice (such as the Code of Practice for Wholesale Dealers) and covers all requirements that licence holders must meet. It includes item-by-item checks of the physical conditions of the premises (such as area, layout, security and temperature and humidity controls), facilities and equipment, the Quality Management System (QMS) (including the completeness and practicability of SOPs), document and record management (such as batch records and temperature and humidity records), personnel qualifications and training records, and specific procedures (such as receipt, storage, picking, dispatch and recall). Although this internal checklist is not published, all its inspection points are derived from published legislation and guidance. An experienced consultant can therefore accurately predict most of its contents.

📘 Regulatory basis

The inspection checklist is an internal tool used by the regulatory authority to ensure that its inspections are standardised, systematic and fair. Its legal basis is the power conferred on Department of Health inspectors by the Pharmacy and Poisons Ordinance to enter and inspect licensed premises.

📗 Drew Tang's recommendations

One of our core strengths at RGYS: RGYS may assist with document preparation and project coordination within the written scope of services; the respective responsible parties must verify personnel qualifications and statutory roles and take responsibility for professional judgements, while approval is determined independently by the competent authority. RGYS may assist with document preparation and project coordination within the written scope of services; the respective responsible parties must verify personnel qualifications and statutory roles and take responsibility for professional judgements, while approval is determined independently by the competent authority. Before the official inspection, we will use this checklist to conduct a "pixel-level" mock audit of your premises and documents, identifying and correcting all potential issues to ensure that, when you face the actual inspector, RGYS may assist with document preparation and project coordination within the written scope of services; the respective responsible parties must verify personnel qualifications and statutory roles and take responsibility for professional judgements, while approval is determined independently by the competent authority.

📕 Risk notice

The risk lies in misjudging the scope of an inspection. Some applicants may focus only on warehouse facilities and overlook the importance of “soft” elements such as records and staff training. Inspections are comprehensive, and a deficiency in any area may result in failure. For example, even if your cold room is state of the art, the inspection result will inevitably be unsatisfactory if you cannot produce a complete temperature validation report.

Q234 · 如果我的申请获得了批准，牌照上会列明我可以批发的具体药品种类吗？独立链接

No. In most cases, a Hong Kong Wholesale Dealer Licence is a “general” authorisation permitting wholesale dealing in pharmaceutical products and/or poisons. The licence itself does not list the specific medicine names or therapeutic categories you may deal in. This means that, in theory, once you obtain a Wholesale Dealer Licence, you may wholesale any medicines registered in Hong Kong, whether prescription medicines, medicines subject to supervision in sale or non-prescription medicines, and regardless of their therapeutic area. However, note that if you plan to handle medicines subject to special regulatory requirements, such as Dangerous Drugs or Antibiotics, you may need to meet additional storage and record-keeping requirements and obtain a specific endorsement on the licence. For the vast majority of ordinary medicines, however, the scope of the licence is broad.

📘 Regulatory basis

The format and scope of authorisation of a licence are prescribed by the Pharmacy and Poisons Regulations. Additional controls for special medicines such as dangerous drugs derive from other relevant legislation, including the Dangerous Drugs Ordinance (Cap. 134).

📗 Drew Tang's recommendations

Although the licence authorises a broad scope of activities, we recommend focusing in the early stages of operations on the product areas with which you are familiar and which are clearly specified in your business plan. We will ensure that your SOPs and facilities fully support the types of products you currently handle and plan to handle in the near future. If you later plan to expand into new product areas with special requirements, such as cold-chain products, we will help you update your SOPs and assess whether your existing facilities need to be upgraded, so that your business expansion remains compliant.

📕 Risk notice

The risk lies in misunderstanding “general authorisation” and assuming that all medicines can be handled without distinction. If you start wholesaling vaccines without the appropriate cold-chain facilities and procedures, even with a valid Wholesale Dealer Licence, this would be a serious breach because you have failed to meet the GSDP requirements specific to those products. A licence authorises eligibility, but actual operations must be suited to the characteristics of the products.

Q235 · 申请牌照的费用（如申请费和牌照费）是否可以退还，如果我的申请被拒绝？独立链接

For refunds, you need to distinguish between two main types of fees: the application fee and the licence fee. The application fee is payable when you submit your application and covers the administrative costs incurred by the Department of Health in processing and reviewing it. It is non-refundable whether your application is approved or rejected. For example, the application fee for a wholesaler’s licence is HKD$1,030 (the fee may be revised; refer to the official source). The licence fee, by contrast, is payable only after the PPB Committee has formally approved your application and is for obtaining the licence for that year. For example, the issue fee for a wholesaler’s licence is HKD$2,150. If your application is not approved, you will not need to pay the licence fee. In short, the review costs paid are non-refundable, while no fee is charged for a licence entitlement you do not receive.

📘 Regulatory basis

The Schedules to the Pharmacy and Poisons Regulations set out the charges for various applications and licences in detail. The principle underlying government fees is “user pays”, and application fees reflect this principle.

📗 Drew Tang's recommendations

Given that the application fee is a sunk cost, we should focus on maximising the likelihood of success on the first application to avoid paying the fee again. Although investing in professional consultancy services increases initial expenditure, by improving the likelihood of approval on the first attempt, it can in practice save you the cost of repeat application fees, additional time and lost opportunities resulting from an unsuccessful application, making it the more cost-effective choice.

📕 Risk notice

The risk lies in seeing that the application fee is relatively small and underestimating the total investment for the entire application process. Beyond government fees, the greater costs are rent for the premises, fitting-out, staff salaries and consultancy fees. If an application fails, all these investments may generate no return for months or even more than a year. That is the greatest financial risk.

Q236 · 我的公司名称或logo是否需要经过卫生署的审批？独立链接

The Department of Health does not carry out additional approval of your company’s legal name. Provided your company is lawfully registered with the Hong Kong Companies Registry, its legal name will be accepted. However, care is needed with any trade name or logo you plan to use, particularly on the signboard of a pharmacy or drug store, to avoid misleading the public. For example, a drug store holding only a Listed Seller of Poisons (LSP) licence must not use terms such as “pharmacy” or “pharmacist-managed”, or similar wording, in its name or logo, as this could mislead consumers into believing that the shop provides services by a registered pharmacist and can dispense prescription medicines. During an on-site inspection, inspectors will check your shop signboard and internal signage to ensure that the promotional content is consistent with your licence type. This is less of an issue for wholesalers, but they should also avoid exaggerated or false promotional claims.

📘 Regulatory basis

The Undesirable Medical Advertisements Ordinance (Cap. 231) prohibits the publication of any advertisement that may cause, or is intended to cause, another person to use a medicine for an improper purpose. The Trade Descriptions Ordinance (Cap. 362) also prohibits the use of false trade descriptions in relation to services.

📗 Drew Tang's recommendations

Before finalising your shop sign design or company marketing materials, we recommend asking our consultants to conduct a compliance review. Based on your licence type, we will check your wording and design for any potential risk of misleading customers, helping you avoid unnecessary legal problems at the outset. A compliant and professional brand image is the foundation for long-term business success.

📕 Risk notice

The risk lies in using a misleading name or sign. If the words “Pharmacy” appear on your dispensary’s sign, you may be required to take immediate corrective action during an inspection and may also face prosecution by the Department of Health. This behaviour seriously damages the professional image of the industry, and the regulator takes a zero-tolerance approach to it. Incorrect naming may delay your licence application or even affect its final approval.

Q237 · 如果我计划搬迁我的药品仓库地址，需要履行什么审批程序？独立链接

If you plan to relocate your pharmaceutical warehouse, this is a major change and you must not simply “move first and report later”. You must treat it as a new “mini” licence application. The correct procedure is as follows: first, preferably have a professional consultant assess the new premises for compliance before signing a tenancy agreement. You then need to submit a formal “Change of Premises” application to the Drug Office, Department of Health. This application must include detailed plans of the new premises, the tenancy agreement and a statement explaining why relocation is necessary. The Department of Health will conduct a full on-site inspection of the new premises as it would for a new application. You may only start moving medicines to the new address after the new premises has passed inspection and you have received formal written approval from the Department of Health for the change of address. Until approval is granted, you must continue operating at your existing licensed address.

📘 Regulatory basis

Your medicine licence is tied to a specific licensed address. Storing or wholesaling medicines at an unapproved address is equivalent to operating without a licence. The Code of Practice for Wholesale Dealers also expressly requires prior approval from the Department of Health for any significant change to the premises.

📗 Drew Tang's recommendations

We will manage the entire relocation process for you. From selecting the new premises and designing the layout plan to submitting a change application to the Department of Health and preparing the new premises for an on-site inspection, we will support you throughout. We will also help you plan a seamless relocation to ensure that your business operations and compliance status are not affected during the transition to the new address.

📕 Risk notice

The greatest risk is “moving first and notifying later”. If you move medicines to a new address without approval, the Department of Health may immediately suspend or even revoke your licence if it discovers this. This is an absolute red line. Another risk is signing a new lease without adequate assessment, only to find that the new premises cannot meet compliance requirements, leaving you in a dilemma.

Q238 · 除了卫生署，申请药品牌照是否还需要与其他香港政府部门打交道？独立链接

In the main pharmaceutical licence application process, your primary and most direct contacts are the Department of Health (including its Drug Office or Chinese Medicine Regulatory Office) and the Pharmacy and Poisons Board (PPB). However, during the preparation and operation of your business, you may need to interact with other government departments. First, you must register the company with the Companies Registry and obtain a Business Registration certificate from the Business Registration Office of the Inland Revenue Department. Your business premises must also comply with the fire safety requirements of the Fire Services Department and the building safety standards of the Buildings Department. Although you will not normally need to apply directly to these two departments when applying for a pharmaceutical licence, Department of Health inspectors will check during their inspection that your premises have basic fire safety facilities, such as fire extinguishers and emergency exit signs, and are structurally safe. If your business involves imports or exports, you will also need to deal with Hong Kong Customs and may need to apply for relevant import or export licences.

📘 Regulatory basis

The Companies Ordinance, Business Registration Ordinance, Fire Safety (Buildings) Ordinance, Buildings Ordinance and Import and Export Ordinance, among others, are basic laws that businesses in Hong Kong must comply with and are closely related to your drug licence application and operations.

📗 Drew Tang's recommendations

We provide an integrated solution. When assessing and designing a warehouse for you, we consider not only the Department of Health's requirements, but also basic fire safety and building safety requirements, conducting a comprehensive compliance review. If your business requires it, we can also help you with customs-related import and export licensing matters to ensure that your business is lawful and compliant in all respects in Hong Kong.

📕 Risk notice

The risk lies in overlooking these “peripheral” but equally important compliance requirements. For example, your warehouse may pass inspection by the Department of Health, but if a routine inspection by the Fire Services Department finds blocked fire escape routes or expired fire equipment, you may still face a fine or an order to suspend operations for remedial work. A successful business must establish a comprehensive culture of compliance, rather than meeting the requirements of only one regulator.

Q239 · 在审批过程中，监管机构会审查我的商业计划书（Business Plan）吗？独立链接

The official requirements for a pharmaceutical licence application in Hong Kong do not make it mandatory for applicants to submit a detailed business plan. The regulatory authorities’ main concern is whether you meet the statutory compliance requirements for premises, personnel and the QMS. They are more concerned with “how you will operate compliantly” than with “how you will make a profit”. This does not mean, however, that a business plan is of no use. Although it is not required, a professional and rigorous business plan can be a very persuasive supporting document. It can help reviewing officers better understand your business model, company background, management team’s expertise and commitment to long-term compliant operations. In some borderline cases—for example, where the Responsible Person (RP) has an unconventional background—a business plan setting out a clear development roadmap and sound financial projections may provide useful support.

📘 Regulatory basis

The legal basis for approval is the Pharmacy and Poisons Ordinance and its subsidiary legislation. These laws focus primarily on public health and pharmaceutical safety, not commercial viability. A business plan is therefore not a statutory submission document.

📗 Drew Tang's recommendations

We recommend that clients prepare a concise yet professional business plan summary as an attachment to the application. We will help you highlight compliance-related matters in the summary, such as the company’s commitment to quality management, staff training plans and strategic reasons for choosing Hong Kong as a business base. This presents your capability and commitment to regulators in a highly professional manner and helps create a positive impression.

📕 Risk notice

The risk lies in submitting a business plan that is exaggerated, unrealistic or riddled with compliance gaps. For example, the proposed business scope may far exceed what your current facilities and personnel can support, or the marketing section may make prohibited medical claims. A document intended to be “clever” may instead raise the regulator’s concerns and lead to closer scrutiny of your application.

Q240 · 什么是“良好分销规范”（GSDP）？它在牌照审批中扮演什么角色？独立链接

“Good Storage and Distribution Practices” (GSDP) is an internationally recognised quality management standard intended to ensure that medicines retain their quality, safety and efficacy throughout the distribution chain, from the manufacturer to the end user. It is not a specific law, but a set of guiding principles and a code of practice. In Hong Kong, the “Code of Practice for Licensed Wholesalers” issued by the PPB is based on GSDP principles. GSDP plays a central and decisive role in licence approval. The entire approval process, from document review to on-site inspection, is essentially an assessment of whether your company can meet GSDP requirements. Everything—including the design of your premises, staffing, SOPs and document-recording system—must be established around the principles of GSDP. GSDP is, in effect, the “rules of the game” for the pharmaceutical wholesale industry. If you cannot demonstrate that you can comply with these rules, you cannot obtain entry (that is, a Wholesale Dealer Licence).

📘 Regulatory basis

The Code of Practice for Holders of Wholesale Dealer Licences, issued by the Pharmacy and Poisons Board (PPB) of Hong Kong, is the local Good Storage and Distribution Practice (GSDP) standard and the fundamental basis for licence applications and subsequent regulation.

📗 Drew Tang's recommendations

We are not only licence application consultants; we are also practitioners with expertise in GSDP. We incorporate GSDP principles into every aspect of our service. We will not simply tell you “what to do”; we will also explain “why”, helping your team truly understand the spirit of GSDP. Our aim is to establish a GSDP system for you that not only passes inspections, but also operates effectively over the long term and continuously improves quality.

📕 Risk notice

The greatest risk is treating GSDP as nothing more than a pile of documents to get through an inspection. If management and staff do not genuinely recognise the importance of GSDP, non-compliant practices will inevitably become widespread in day-to-day operations, even if you manage to pass the initial inspection. This disconnect between the system and practice is easily exposed during a Department of Health spot check, ultimately putting your licence at risk.

Hong Kong Drug Licence FAQs

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang